News
Hosted on MSN1m
Biocon eyes generic Wegovy obesity drug launch in India, Canada in next 2 years, CEO saysThe push comes after Danish drugmaker Novo Nordisk and U.S.-based rival Eli Lilly saw skyrocketing demand for their obesity ...
You have been exercising, eating home-cooked meals, and have managed to cut out fried food and desserts from your diet for ...
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...
Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient models from Eli Lilly and Novo Nordisk.
Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...
PORTLAND, OR, UNITED STATES, July 17, 2025 /EINPresswire.com/ -- The global anti-obesity drugs market, valued at $1,605.36 million in 2022, is projected to reach $4,439.34 million by 2032, expanding ...
Executives and directors of Hims & Hers Health Inc., a leading telehealth company, are facing a shareholder derivative ...
Many US employers plan to pare health benefits as weight-loss spending soars - Nation and World News | Hawaii Tribune-Herald ...
NEW YORK >> More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from ...
Albertsons CEO Susan Morris said she had to "double-check the numbers" when she saw how much cottage cheese the chain was ...
In an echo of the pattern laid last year, following a record-high outlay at the very beginning of the year, TV drug ad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results